rs139194076
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001008537.3(NEXMIF):c.2139G>A(p.Glu713Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,209,683 control chromosomes in the GnomAD database, including 1 homozygotes. There are 195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00054 ( 0 hom., 15 hem., cov: 23)
Exomes 𝑓: 0.00047 ( 1 hom. 180 hem. )
Consequence
NEXMIF
NM_001008537.3 synonymous
NM_001008537.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.623
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-74742418-C-T is Benign according to our data. Variant chrX-74742418-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 541133.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-74742418-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.623 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 15 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.2139G>A | p.Glu713Glu | synonymous_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.2139G>A | p.Glu713Glu | synonymous_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682.5 | ||
NEXMIF | ENST00000616200.2 | c.2139G>A | p.Glu713Glu | synonymous_variant | 3/5 | 1 | ENSP00000480284.1 | |||
NEXMIF | ENST00000642681.2 | c.2139G>A | p.Glu713Glu | synonymous_variant | 3/3 | ENSP00000495800.1 |
Frequencies
GnomAD3 genomes AF: 0.000537 AC: 60AN: 111800Hom.: 0 Cov.: 23 AF XY: 0.000442 AC XY: 15AN XY: 33966
GnomAD3 genomes
AF:
AC:
60
AN:
111800
Hom.:
Cov.:
23
AF XY:
AC XY:
15
AN XY:
33966
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000855 AC: 156AN: 182492Hom.: 0 AF XY: 0.000848 AC XY: 57AN XY: 67246
GnomAD3 exomes
AF:
AC:
156
AN:
182492
Hom.:
AF XY:
AC XY:
57
AN XY:
67246
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000472 AC: 518AN: 1097829Hom.: 1 Cov.: 31 AF XY: 0.000496 AC XY: 180AN XY: 363231
GnomAD4 exome
AF:
AC:
518
AN:
1097829
Hom.:
Cov.:
31
AF XY:
AC XY:
180
AN XY:
363231
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000536 AC: 60AN: 111854Hom.: 0 Cov.: 23 AF XY: 0.000441 AC XY: 15AN XY: 34030
GnomAD4 genome
AF:
AC:
60
AN:
111854
Hom.:
Cov.:
23
AF XY:
AC XY:
15
AN XY:
34030
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 19, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
NEXMIF-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at